298 related articles for article (PubMed ID: 12006603)
1. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor.
Xie L; Helmerhorst E; Taddei K; Plewright B; Van Bronswijk W; Martins R
J Neurosci; 2002 May; 22(10):RC221. PubMed ID: 12006603
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor.
Ling X; Martins RN; Racchi M; Craft S; Helmerhorst E
J Alzheimers Dis; 2002 Oct; 4(5):369-74. PubMed ID: 12446969
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
[TBL] [Abstract][Full Text] [Related]
4. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease.
Verdier Y; Penke B
Curr Protein Pept Sci; 2004 Feb; 5(1):19-31. PubMed ID: 14965318
[TBL] [Abstract][Full Text] [Related]
5. Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide.
Mustafi SM; Garai K; Crick SL; Baban B; Frieden C
Biochem Biophys Res Commun; 2010 Jul; 397(3):509-12. PubMed ID: 20515649
[TBL] [Abstract][Full Text] [Related]
6. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK
FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal Molecular Interactions between the Aβ Peptide Linked to Alzheimer's Disease and Insulin Linked to Diabetes Mellitus Type II.
Luo J; Wärmländer SK; Gräslund A; Abrahams JP
ACS Chem Neurosci; 2016 Mar; 7(3):269-74. PubMed ID: 26785771
[TBL] [Abstract][Full Text] [Related]
8. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
Oyama R; Yamamoto H; Titani K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
[TBL] [Abstract][Full Text] [Related]
12. Conformations and biological activities of amyloid beta peptide 25-35.
Millucci L; Ghezzi L; Bernardini G; Santucci A
Curr Protein Pept Sci; 2010 Feb; 11(1):54-67. PubMed ID: 20201807
[TBL] [Abstract][Full Text] [Related]
13. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
Butterfield DA; Kanski J
Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
[TBL] [Abstract][Full Text] [Related]
14. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
16. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
17. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
19. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.
Suo Z; Humphrey J; Kundtz A; Sethi F; Placzek A; Crawford F; Mullan M
Neurosci Lett; 1998 Nov; 257(2):77-80. PubMed ID: 9865931
[TBL] [Abstract][Full Text] [Related]
20. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]